EC
EntryPoint Capital Portfolio holdings
AUM
$200M
1-Year Return
6.93%
This Quarter Return
+2.29%
1 Year Return
+6.93%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$112M
AUM Growth
+$7.22M
(+6.9%)
Cap. Flow
+$4.02M
Cap. Flow
% of AUM
3.6%
Top 10 Holdings %
Top 10 Hldgs %
3.56%
Holding
1,843
New
513
Increased
412
Reduced
455
Closed
458
Top Buys
| 1 |
Unisys
UIS
|
$454K |
| 2 |
Sutro Biopharma
STRO
|
$394K |
| 3 |
Agilysys
AGYS
|
$382K |
| 4 |
Schrodinger
SDGR
|
$371K |
| 5 |
REV Group
REVG
|
$345K |
Top Sells
| 1 |
NextDecade
NEXT
|
$643K |
| 2 |
American Well
AMWL
|
$535K |
| 3 |
B. Riley Financial
RILY
|
$524K |
| 4 |
Lexicon Pharmaceuticals
LXRX
|
$496K |
| 5 |
Taysha Gene Therapies
TSHA
|
$484K |
Sector Composition
| 1 | Healthcare | 20.49% |
| 2 | Industrials | 17.08% |
| 3 | Technology | 16.88% |
| 4 | Financials | 12.63% |
| 5 | Consumer Discretionary | 12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
SPS Commerce
SPSC
$4.19B
| $157K | 0.14% |
+848
| New | +$157K |
|
202
PJT Partners
PJT
$4.38B
| $157K | 0.14% |
1,662
+359
| +28% | +$33.8K |
|
203
Primoris Services
PRIM
$6.32B
| $157K | 0.14% |
3,677
+513
| +16% | +$21.8K |
|
204
NMI Holdings
NMIH
$3.1B
| $156K | 0.14% |
4,816
-749
| -13% | -$24.2K |
|
205
Amicus Therapeutics
FOLD
$2.46B
| $156K | 0.14% |
13,218
+9,729
| +279% | +$115K |
|
206
Universal Corp
UVV
$1.38B
| $156K | 0.14% |
+3,008
| New | +$156K |
|
|
DCPH
207
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $154K | 0.14% |
9,795
-775
| -7% | -$12.2K |
|
208
Warner Bros
WBD
$30B
| $154K | 0.14% |
17,611
+6,442
| +58% | +$56.2K |
|
209
Deluxe
DLX
$876M
| $153K | 0.14% |
+7,450
| New | +$153K |
|
210
Gilead Sciences
GILD
$143B
| $153K | 0.14% |
2,094
-355
| -14% | -$26K |
|
211
Groupon
GRPN
$971M
| $153K | 0.14% |
+11,498
| New | +$153K |
|
|
IGMS
212
DELISTED
IGM Biosciences
IGMS
| $152K | 0.14% |
+15,801
| New | +$152K |
|
213
National Presto Industries
NPK
$782M
| $152K | 0.14% |
+1,819
| New | +$152K |
|
214
CSG Systems International
CSGS
$1.86B
| $152K | 0.14% |
2,953
+158
| +6% | +$8.14K |
|
215
Progyny
PGNY
$1.94B
| $152K | 0.14% |
3,989
+1,892
| +90% | +$72.2K |
|
|
ITCI
216
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $150K | 0.13% |
2,167
+1,259
| +139% | +$87.1K |
|
217
Vertiv
VRT
$47.4B
| $150K | 0.13% |
1,832
-3,360
| -65% | -$274K |
|
218
Calavo Growers
CVGW
$485M
| $150K | 0.13% |
5,380
+4,094
| +318% | +$114K |
|
219
iRadimed
IRMD
$916M
| $150K | 0.13% |
+3,399
| New | +$150K |
|
220
Conduent
CNDT
$447M
| $149K | 0.13% |
44,162
-40,046
| -48% | -$135K |
|
221
Matrix Service
MTRX
$403M
| $149K | 0.13% |
11,434
-11,889
| -51% | -$155K |
|
222
Donaldson
DCI
$9.44B
| $148K | 0.13% |
1,986
+938
| +90% | +$70.1K |
|
223
3M
MMM
$82.7B
| $148K | 0.13% |
1,995
+1,500
| +303% | +$111K |
|
224
Movado Group
MOV
$431M
| $148K | 0.13% |
5,293
+1,859
| +54% | +$51.9K |
|
225
Lam Research
LRCX
$130B
| $148K | 0.13% |
1,520
+1,190
| +361% | +$116K |
|